Javascript must be enabled to continue!
Clinical outcome of using gastric remnant or jejunum or colon conduit in surgery for esophageal carcinoma with previous gastrectomy
View through CrossRef
BackgroundFor esophageal carcinoma patients with early gastrectomy, individualized surgical plans—including selection of replacement conduit and operation route based on patient's new lesion and surgical history—can achieve the desired therapeutic effect and improve postoperative life quality. We investigated the outcomes at our institution.MethodsThe clinical data of 42 esophageal carcinoma patients with early gastrectomy were analyzed retrospectively.ResultsEsophagectomy was performed combining replacement with remnant stomach in 16 patients, jejunum in 17, and colon in 9. Esophagectomy combining replacement with gastric remnant got advantages of shorter operation time and less bleeding over that of replacement with jejunum or colon. Gastric remnant group scored higher on the QLQ‐C30 questionnaire than jejunum or colon group with respect to overall quality of life, physical function, and social relationships. In QLQ‐OES18 questionnaire, the scores of appetite recovery and reflux mitigation were more favorable in remnant stomach group than those in jejunum or colon group. Survival analysis showed no significant difference in survival rate among the patients undergoing replacement with gastric remnant, jejunum, or colon.ConclusionsFor esophageal carcinoma patients with early gastrectomy, esophagus‐gastric remnant anastomosis possesses advantages of shorter operation time, less surgical trauma, and greater life quality after surgery.
Title: Clinical outcome of using gastric remnant or jejunum or colon conduit in surgery for esophageal carcinoma with previous gastrectomy
Description:
BackgroundFor esophageal carcinoma patients with early gastrectomy, individualized surgical plans—including selection of replacement conduit and operation route based on patient's new lesion and surgical history—can achieve the desired therapeutic effect and improve postoperative life quality.
We investigated the outcomes at our institution.
MethodsThe clinical data of 42 esophageal carcinoma patients with early gastrectomy were analyzed retrospectively.
ResultsEsophagectomy was performed combining replacement with remnant stomach in 16 patients, jejunum in 17, and colon in 9.
Esophagectomy combining replacement with gastric remnant got advantages of shorter operation time and less bleeding over that of replacement with jejunum or colon.
Gastric remnant group scored higher on the QLQ‐C30 questionnaire than jejunum or colon group with respect to overall quality of life, physical function, and social relationships.
In QLQ‐OES18 questionnaire, the scores of appetite recovery and reflux mitigation were more favorable in remnant stomach group than those in jejunum or colon group.
Survival analysis showed no significant difference in survival rate among the patients undergoing replacement with gastric remnant, jejunum, or colon.
ConclusionsFor esophageal carcinoma patients with early gastrectomy, esophagus‐gastric remnant anastomosis possesses advantages of shorter operation time, less surgical trauma, and greater life quality after surgery.
Related Results
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract
Introduction
Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Abstracts for the 6th European Symposium on Gastrointestinal Motility 19–21 NOVEMBER 1992 HOTEL MELIA BARCELONA, BARCELONA, SPAIN
Abstracts for the 6th European Symposium on Gastrointestinal Motility 19–21 NOVEMBER 1992 HOTEL MELIA BARCELONA, BARCELONA, SPAIN
MOTOR RESPONSES OF HUMAN ILEUM TO TACHYKININS IN VITRO: EXISTENCE OF NK2 RECEPTORS AND RECEPTORS SPECIFIC FOR NEUROPEPTIDE GAMMA.INNERVATION OF THE MUSCULARIS MUCOSAE OF HUMAN COLO...
Studies on fatty acids and microbiota characterization of the gastrointestinal tract of Tianzhu white yaks
Studies on fatty acids and microbiota characterization of the gastrointestinal tract of Tianzhu white yaks
IntroductionThe gut microbiota significantly influences the host’s production performance and health status, with different gastrointestinal tissues exhibiting functional diversity...
The analysis on Tiam2 for expression in esophageal carcinoma: A descriptive study
The analysis on Tiam2 for expression in esophageal carcinoma: A descriptive study
Rationale:
To investigate T lymphoma invasion and metastasis inducing factor 2 (Tiam2) protein for expression in esophageal carcinoma and relationship with clinical fea...
A46 PER-ORAL ENDOSCOPIC MYOTOMY ALLEVIATES HELICAL STENOSIS OF A GASTRIC CONDUIT POST-ESOPHAGECTOMY: A CASE REPORT
A46 PER-ORAL ENDOSCOPIC MYOTOMY ALLEVIATES HELICAL STENOSIS OF A GASTRIC CONDUIT POST-ESOPHAGECTOMY: A CASE REPORT
Abstract
Background
Gastric conduit dysfunction is a common post-operative complication of esophagectomy. Established treatments...
Gastric Pyloric Schwannoma: A Case Report and Review of the Literature
Gastric Pyloric Schwannoma: A Case Report and Review of the Literature
Abstract
Introduction
Schwannomas are slow-growing, subclinical neoplasms rarely found in the gastrointestinal tract. This study reports a schwannoma in the pyloric region of the s...
Laparoscopic-assisted Gastrectomy for Gastric Cancer with D2 Lymphadenectomy: Experience with more than 500 Cases at Military Hospital, Vietnam
Laparoscopic-assisted Gastrectomy for Gastric Cancer with D2 Lymphadenectomy: Experience with more than 500 Cases at Military Hospital, Vietnam
BACKGROUND: Among the less invasive operations noted in recent years, laparoscopic gastrectomy (LG) for gastric cancer has become popular because of advances in surgical techniques...
022. TREATMENT EXPERIENCE OF ESOPHAGEAL FISTULA INDUCED BY NEOADJUVANT THERAPY IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA: A SINGLE-CENTER EXPERIENCE
022. TREATMENT EXPERIENCE OF ESOPHAGEAL FISTULA INDUCED BY NEOADJUVANT THERAPY IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA: A SINGLE-CENTER EXPERIENCE
Abstract
Background
Esophageal squamous cell carcinoma (ESCC) is typically treated with neoadjuvant therapy followed by esophage...

